Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?

Background & Aims. Endometrial tubal metaplasia (ETM) is mostly described in conjunction with unopposed estrogen levels, and its association with endometrial hyperplasia and endometrial carcinoma (EC) is striking. Obesity is a risk factor for endometrial hyperplasia and EC development. The aim o...

Full description

Bibliographic Details
Main Authors: Ayman M. El-Saka, Yomna A. Zamzam, Yosra A. Zamzam, Ayman El-Dorf
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Journal of Obesity
Online Access:http://dx.doi.org/10.1155/2020/2825905
id doaj-edb82a7988b845879e68ec7ce7b93962
record_format Article
spelling doaj-edb82a7988b845879e68ec7ce7b939622020-11-25T02:59:32ZengHindawi LimitedJournal of Obesity2090-07082090-07162020-01-01202010.1155/2020/28259052825905Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?Ayman M. El-Saka0Yomna A. Zamzam1Yosra A. Zamzam2Ayman El-Dorf3Department of Pathology, Faculty of Medicine, Tanta University, Tanta, EgyptDepartment of Pathology, Faculty of Medicine, Tanta University, Tanta, EgyptDepartment of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, EgyptDepartment of Gynecology and Obstetrics, Faculty of Medicine, Tanta University, Tanta, EgyptBackground & Aims. Endometrial tubal metaplasia (ETM) is mostly described in conjunction with unopposed estrogen levels, and its association with endometrial hyperplasia and endometrial carcinoma (EC) is striking. Obesity is a risk factor for endometrial hyperplasia and EC development. The aim of this study is to investigate the impact of BMI and serum estradiol level on expression of PAX-2, H-TERT, P16, Ki-67, and P53 in studied ETM in reference to benign endometrium and EC. Methods. The study was conducted on the following groups: group (1) consists of 57 cases that had endometrial biopsies with histologically demonstrable ETM (typical or atypical) and all were subjected to serum estradiol levelling and body mass index (BMI) evaluation; group (2) had adjacent benign endometrial tissue as control; group (3) consists of 52 cases of conventional endometrial carcinoma and 16 serous carcinoma paraffin blocks which were collected and reevaluated. All included groups were immunostained for PAX-2, H-TERT, p16, ki67, and p53. Results. The relation between BMI and serum estradiol level in group 1 and PAX-2, H-TERT, P16, and p53 was statistically significant, while their relation with atypia and ki67 expression was insignificant. Twenty-three ETM cases (40.4%) out of group 1 were all (100%) obese, 87% had high serum estradiol level, and 73.9% were postmenopausal and had a similar immunohistochemical profile as EC cases (group 3). Conclusions. The presence of ETM regardless of the histologic atypia in obese postmenopausal patients with high serum estradiol level is an alarming sign. This implies that ETM might not be as benign as generally accepted, as under certain clinical conditions, it may turn into a potential premalignant lesion.http://dx.doi.org/10.1155/2020/2825905
collection DOAJ
language English
format Article
sources DOAJ
author Ayman M. El-Saka
Yomna A. Zamzam
Yosra A. Zamzam
Ayman El-Dorf
spellingShingle Ayman M. El-Saka
Yomna A. Zamzam
Yosra A. Zamzam
Ayman El-Dorf
Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?
Journal of Obesity
author_facet Ayman M. El-Saka
Yomna A. Zamzam
Yosra A. Zamzam
Ayman El-Dorf
author_sort Ayman M. El-Saka
title Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?
title_short Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?
title_full Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?
title_fullStr Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?
title_full_unstemmed Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?
title_sort could obesity be a triggering factor for endometrial tubal metaplasia to be a precancerous lesion?
publisher Hindawi Limited
series Journal of Obesity
issn 2090-0708
2090-0716
publishDate 2020-01-01
description Background & Aims. Endometrial tubal metaplasia (ETM) is mostly described in conjunction with unopposed estrogen levels, and its association with endometrial hyperplasia and endometrial carcinoma (EC) is striking. Obesity is a risk factor for endometrial hyperplasia and EC development. The aim of this study is to investigate the impact of BMI and serum estradiol level on expression of PAX-2, H-TERT, P16, Ki-67, and P53 in studied ETM in reference to benign endometrium and EC. Methods. The study was conducted on the following groups: group (1) consists of 57 cases that had endometrial biopsies with histologically demonstrable ETM (typical or atypical) and all were subjected to serum estradiol levelling and body mass index (BMI) evaluation; group (2) had adjacent benign endometrial tissue as control; group (3) consists of 52 cases of conventional endometrial carcinoma and 16 serous carcinoma paraffin blocks which were collected and reevaluated. All included groups were immunostained for PAX-2, H-TERT, p16, ki67, and p53. Results. The relation between BMI and serum estradiol level in group 1 and PAX-2, H-TERT, P16, and p53 was statistically significant, while their relation with atypia and ki67 expression was insignificant. Twenty-three ETM cases (40.4%) out of group 1 were all (100%) obese, 87% had high serum estradiol level, and 73.9% were postmenopausal and had a similar immunohistochemical profile as EC cases (group 3). Conclusions. The presence of ETM regardless of the histologic atypia in obese postmenopausal patients with high serum estradiol level is an alarming sign. This implies that ETM might not be as benign as generally accepted, as under certain clinical conditions, it may turn into a potential premalignant lesion.
url http://dx.doi.org/10.1155/2020/2825905
work_keys_str_mv AT aymanmelsaka couldobesitybeatriggeringfactorforendometrialtubalmetaplasiatobeaprecancerouslesion
AT yomnaazamzam couldobesitybeatriggeringfactorforendometrialtubalmetaplasiatobeaprecancerouslesion
AT yosraazamzam couldobesitybeatriggeringfactorforendometrialtubalmetaplasiatobeaprecancerouslesion
AT aymaneldorf couldobesitybeatriggeringfactorforendometrialtubalmetaplasiatobeaprecancerouslesion
_version_ 1715334093019807744